Changes of Serum Orphanin FQ in Patients With Coronary Heart Disease in Different Courses of Diabetes Mellitus
Study on the Changes of Serum Orphanin FQ in Patients With Diabetes Mellitus and Coronary Heart Disease in Different Courses
1 other identifier
observational
100
1 country
1
Brief Summary
To explore the severity of diabetic patients with coronary heart disease and the change of serum orphanin FQ content in different diabetic courses
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2020
CompletedFirst Posted
Study publicly available on registry
October 1, 2020
CompletedStudy Start
First participant enrolled
October 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedApril 20, 2022
April 1, 2022
8 months
September 29, 2020
April 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gensini score
Gensini score was used to evaluate the severity of coronary artery occlusion, and then compared with the population of type 2 diabetes complicated with coronary heart disease
1 week
Study Arms (4)
control group
Coronary heart disease population: after coronary angiography, Gensini score was used to evaluate the severity of coronary artery occlusion, and then compared with the population of type 2 diabetes complicated with coronary heart disease
experimental group (course of disease <5 years)
Type 2 diabetes complicated with coronary heart disease (course of disease 5-10 years).Retrospective examination of patients' data, recording patients' laboratory tests and drug use, taking blood to measure orphanin, and evaluating the severity of coronary artery occlusion with Gensini score.
experimental group(course of disease 5-10 years)
Type 2 diabetes complicated with coronary heart disease (course of disease 5-10 years).
experimental group(course of disease10-20 years)
Type 2 diabetes complicated with coronary heart disease (course of disease 10 -20years).Finally, the data were obtained to evaluate the relationship between the course of diabetes and the severity of coronary heart disease, as well as the relationship between the course of diabetes and OFQ in patients' blood.
Interventions
Coronary angiography was performed in patients with coronary heart disease complicated with type 2 diabetes mellitus
Eligibility Criteria
Type 2 diabetes complicated with coronary heart disease
You may qualify if:
- The main discharge diagnosis is T2DM;;
- Age \> 18 years old;
- No acute complications of diabetes;
- The previous diagnosis was coronary heart disease
You may not qualify if:
- T1DM patients;
- EGFR \< 60 ml/min/1.73 m or proteinuria (or both);
- Patients with history of acute cardiovascular events;
- Familial hypercholesterolemia or other hereditary lipid metabolism diseases;
- anti-HIV patients;
- Patients with serious mental health problems;
- Patients receiving drugs that can lead to dyslipidemia, such as antipsychotics, corticosteroids, or immunosuppressants;
- Patients with systemic inflammatory diseases, such as systemic lupus erythematosus; Pet-name ruby is quitting smoking and severe obesity (BMI\>40).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Second of Shanxi Medical University
Taiyuan, Shanxi, 030001, China
Biospecimen
Serum orphanin FQ,Glycosylated hemoglobin
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
zheng guo, doctor
Second Hospital of Shanxi Medical University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigation
Study Record Dates
First Submitted
September 29, 2020
First Posted
October 1, 2020
Study Start
October 10, 2020
Primary Completion
June 1, 2021
Study Completion
September 30, 2021
Last Updated
April 20, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share
All IPD that underlie results in a publication